These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
688 related articles for article (PubMed ID: 35256941)
1. Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane Wang X; Chen X; Zhou W; Men H; Bao T; Sun Y; Wang Q; Tan Y; Keller BB; Tong Q; Zheng Y; Cai L Acta Pharm Sin B; 2022 Feb; 12(2):708-722. PubMed ID: 35256941 [TBL] [Abstract][Full Text] [Related]
2. Empagliflozin attenuates the renal tubular ferroptosis in diabetic kidney disease through AMPK/NRF2 pathway. Lu Q; Yang L; Xiao JJ; Liu Q; Ni L; Hu JW; Yu H; Wu X; Zhang BF Free Radic Biol Med; 2023 Feb; 195():89-102. PubMed ID: 36581059 [TBL] [Abstract][Full Text] [Related]
3. What is the impact of ferroptosis on diabetic cardiomyopathy: a systematic review. Lou X; Zhang Y; Guo J; Gao L; Ding Y; Zhuo X; Lei Q; Bian J; Lei R; Gong W; Zhang X; Jiao Q Heart Fail Rev; 2024 Jan; 29(1):1-11. PubMed ID: 37555989 [TBL] [Abstract][Full Text] [Related]
4. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function. Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979 [TBL] [Abstract][Full Text] [Related]
5. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function. Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart. Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083 [TBL] [Abstract][Full Text] [Related]
7. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis. Wang Z; Yao M; Jiang L; Wang L; Yang Y; Wang Q; Qian X; Zhao Y; Qian J Biomed Pharmacother; 2022 Oct; 154():113572. PubMed ID: 35988428 [TBL] [Abstract][Full Text] [Related]
9. Loss of Cardiac Ferritin H Facilitates Cardiomyopathy via Slc7a11-Mediated Ferroptosis. Fang X; Cai Z; Wang H; Han D; Cheng Q; Zhang P; Gao F; Yu Y; Song Z; Wu Q; An P; Huang S; Pan J; Chen HZ; Chen J; Linkermann A; Min J; Wang F Circ Res; 2020 Jul; 127(4):486-501. PubMed ID: 32349646 [TBL] [Abstract][Full Text] [Related]
10. Neuregulin-4 protects cardiomyocytes against high-glucose-induced ferroptosis via the AMPK/NRF2 signalling pathway. Wang P; Guo X; Wang H; Wang L; Ma M; Guo B Biol Direct; 2024 Aug; 19(1):62. PubMed ID: 39095871 [TBL] [Abstract][Full Text] [Related]
11. Ibuprofen induces ferroptosis of glioblastoma cells via downregulation of nuclear factor erythroid 2-related factor 2 signaling pathway. Gao X; Guo N; Xu H; Pan T; Lei H; Yan A; Mi Y; Xu L Anticancer Drugs; 2020 Jan; 31(1):27-34. PubMed ID: 31490283 [TBL] [Abstract][Full Text] [Related]
12. Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway. Zhang W; Lu J; Wang Y; Sun P; Gao T; Xu N; Zhang Y; Xie W Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614295 [TBL] [Abstract][Full Text] [Related]
13. Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy. Du S; Shi H; Xiong L; Wang P; Shi Y Front Endocrinol (Lausanne); 2022; 13():1011669. PubMed ID: 36313744 [TBL] [Abstract][Full Text] [Related]
14. 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement. Zheng Z; Ma T; Guo H; Kim KS; Kim KT; Bi L; Zhang Z; Cai L J Cell Mol Med; 2019 Aug; 23(8):5771-5781. PubMed ID: 31199069 [TBL] [Abstract][Full Text] [Related]
15. Ferroptosis in diabetic cardiomyopathy: Advances in cardiac fibroblast-cardiomyocyte interactions. Wang M; Mo D; Zhang N; Yu H Heliyon; 2024 Aug; 10(15):e35219. PubMed ID: 39165946 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of NF-κB by USP24 aggravates ferroptosis in diabetic cardiomyopathy. Wu S; Zhou Y; Liang J; Ying P; Situ Q; Tan X; Zhu J Free Radic Biol Med; 2024 Jan; 210():352-366. PubMed ID: 38056575 [TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36-mediated ferroptosis. Li X; Li Z; Dong X; Wu Y; Li B; Kuang B; Chen G; Zhang L Phytother Res; 2023 Jul; 37(7):3042-3056. PubMed ID: 36882189 [TBL] [Abstract][Full Text] [Related]
18. Engineered cardiac tissues: a novel in vitro model to investigate the pathophysiology of mouse diabetic cardiomyopathy. Wang X; Chen XX; Yu HT; Tan Y; Lin Q; Keller BB; Zheng Y; Cai L Acta Pharmacol Sin; 2021 Jun; 42(6):932-941. PubMed ID: 33037406 [TBL] [Abstract][Full Text] [Related]
19. Dihydroquercetin suppresses cigarette smoke induced ferroptosis in the pathogenesis of chronic obstructive pulmonary disease by activating Nrf2-mediated pathway. Liu X; Ma Y; Luo L; Zong D; Li H; Zeng Z; Cui Y; Meng W; Chen Y Phytomedicine; 2022 Feb; 96():153894. PubMed ID: 34942457 [TBL] [Abstract][Full Text] [Related]
20. Ferritinophagy is involved in the zinc oxide nanoparticles-induced ferroptosis of vascular endothelial cells. Qin X; Zhang J; Wang B; Xu G; Yang X; Zou Z; Yu C Autophagy; 2021 Dec; 17(12):4266-4285. PubMed ID: 33843441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]